跳至主要内容
临床试验/ACTRN12620001317987
ACTRN12620001317987尚未招募1 期

Does the Concomitant Administration of Proton Pump Inhibitors Effect Capecitabine Pharmacokinetics? – A Prospective, Single-Centre, Two-Arm, Randomised, Unblinded, Cross-Over Bioequivalence Study of Capecitabine With or Without Concomitant Pantoprazole.

Auckland District Health Board0 个研究点目标入组 20 人开始时间: 2020年12月7日最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • adults (18+ years) with histologically confirmed GI or breast cancer, receiving adjuvant or palliative capecitabine monotherapy within the Regional Cancer and Blood Services, Auckland District Health Board. Adequate functional status (ECOG 2 or less) and organ function as defined as (i) Neutrophil>1.5, Hb>9g, Platelet>100,000, (ii) Bilirubin<1.5x ULN, ALT, AST <2.0 ULN, (iii) Creatinine clearance calculated by Cockcroft Gault >50ml/min within 14 days of cycle 1.

排除标准

  • Previous capecitabine use, recent Proton pump inhibitors (PPI), /H2 Receptor Blocker or antacid use, pre-existing gastritis/ gastro-oesophageal reflux necessitating treatment, previous intolerance to PPI and any condition deemed by study investigators to significantly affect normal gastrointestinal tract function (e.g. upper gastrointestinal tract surgery/ radiation/ pre-existing condition)

研究者

相似试验

招募中
4 期
Randomized head-to-head trial of proton pump inhibitor (PPI) vs topical corticosteroids (TCs) post food bolus impaction and/or for untreated patients with Eosinophilic esophagitis (EoE).Eosinophilic oesophagitis (EoE)Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
ACTRN12623000604606orthern Adelaide Local Health Network72
招募中
不适用
A comparative study of the effect of proton pump inhibitor and ranitidine on serum magnesium level and blood pressure in chronic hemodialysis patients with hypotentioRenal failure.End stage renal diseaseN18.6
IRCT20150808023559N19Vice chancellor for research, Ardabil University of Medical Sciences50
已完成
不适用
The Use of Proton Pump Inhibitors in General PracticeDigestive system diseases: Peptic ulcer diseaseDigestive SystemPeptic ulcer
ISRCTN70358598HS R&D Regional Programme Register - Department of Health (UK)
进行中(未招募)
不适用
Phase II clinical study on efficacy of proton pump inhibitors pre-treatment in osteosarcoma patients undergoing chemiotherapy - Proton pump inhibitors in osteosarcoma patientsOsteosarcomaMedDRA version: 9.1Level: LLTClassification code 10031293Term: Osteosarcoma localised
EUCTR2006-005179-17-ITISTITUTI ORTOPEDICI RIZZOLI
尚未招募
不适用
A randomized study of the influence of proton pump inhibitors on antiplatelet effect by Clopidogrel based on CYP2C19 genotypesAngina pectoris and myocardial infarction
JPRN-UMIN000003898ational Cerebral and Cardiovascular Center150